Cowen Starts Corvus Pharmaceuticals (CRVS) at Outperform
Tweet
Share
E-mail
Get Alerts CRVS Hot Sheet
Price: $15.60 +2.83%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 22 | New: 48
Join SI Premium – FREE
Cowen initiated coverage on Corvus Pharmaceuticals (NASDAQ: CRVS) with an Outperform rating.
For an analyst ratings summary and ratings history on Corvus Pharmaceuticals click here. For more ratings news on Corvus Pharmaceuticals click here.
Shares of Corvus Pharmaceuticals closed at $15.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
- TD Cowen: '2Q26 Digital Ad Expert Call: Resilient Consumer Continues to Drive Ad Spend'
- Citi resumes Echo Global Logistics coverage with Buy rating
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
